Gland Pharma Ltd — Syringe Exporter Profile
Indian Pharmaceutical Exporter · #1 for Syringe · $30.9M export value · DGFT Verified
Gland Pharma Ltd is the #1 Indian exporter of Syringe with $30.9M in export value and 619 verified shipments. Gland Pharma Ltd holds a 17.6% market share in Syringe exports across 22 countries.
Gland Pharma Ltd — Syringe Export Profile: Buyers & Destinations
Where Does Gland Pharma Ltd Export Syringe?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $23.9M | 522 | 66.5% |
| SAUDI ARABIA | $4.5M | 95 | 12.6% |
| PERU | $1.2M | 28 | 3.5% |
| THAILAND | $766.4K | 19 | 2.1% |
| CHILE | $663.7K | 18 | 1.8% |
| DOMINICAN REPUBLIC | $597.4K | 23 | 1.7% |
| DOMINICAN REPULIC | $590.1K | 19 | 1.6% |
| KENYA | $552.7K | 14 | 1.5% |
| JAMAICA | $439.1K | 18 | 1.2% |
| PANAMA | $352.2K | 11 | 1.0% |
Gland Pharma Ltd exports Syringe to 29 countries. The largest destination is UNITED STATES accounting for 66.5% of Gland Pharma Ltd's Syringe shipments, followed by SAUDI ARABIA (12.6%) and PERU (3.5%). These destinations reflect Gland Pharma Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Syringe from Gland Pharma Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| FRESENIUS KABI USA, LLC | UNITED STATES | $15.5M | 341 |
| BOSTON ONCOLOGY ARABIA | SAUDI ARABIA | $4.5M | 95 |
| FRESENIUS KABI USA LLC | UNITED STATES | $3.4M | 70 |
| EVERSANA | UNITED STATES | $3.2M | 70 |
| PHARMACEUTICAL TECHNOLOGY | DOMINICAN REPULIC | $1.2M | 42 |
| EVERSANA LIFE SCIENCE SERVICES LLC | UNITED STATES | $1.0M | 24 |
| NORDIC PHARMACEUTICAL COMPANY SAC | PERU | $726.4K | 17 |
| EVERSANA EVERSANA | UNITED STATES | $589.0K | 13 |
| LABORATORIO CHILE S.A | CHILE | $499.4K | 14 |
| NORDIC PHARMACEUTICAL CO SAC | PERU | $350.0K | 7 |
Gland Pharma Ltd supplies Syringe to 56 buyers globally. The largest buyer is FRESENIUS KABI USA, LLC (UNITED STATES), followed by BOSTON ONCOLOGY ARABIA (SAUDI ARABIA) and FRESENIUS KABI USA LLC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Syringe Export Value and How Much Does Gland Pharma Ltd Contribute?
India exported $67.3M worth of Syringe through 3,522 shipments from 291 suppliers to 154 countries, serving 751 buyers globally. Gland Pharma Ltd contributes $30.9M to this total, accounting for 17.6% of India's Syringe exports. Gland Pharma Ltd ships Syringe to 29 countries through 56 buyers.
What Is the Average Shipment Value for Gland Pharma Ltd's Syringe Exports?
Gland Pharma Ltd's average Syringe shipment value is $50.0K per consignment, based on 619 shipments totaling $30.9M. The largest destination is UNITED STATES (66.5% of Gland Pharma Ltd's Syringe exports).
How Does Gland Pharma Ltd Compare to Other Indian Syringe Exporters?
Gland Pharma Ltd ranks #1 among 291 Indian Syringe exporters with a 17.6% market share. The top 3 exporters are GLAND PHARMA LTD ($30.9M), GLAND PHARMA LIMITED ($11.7M), INDIAN IMMUNOLOGICALS LIMITED ($7.9M). Gland Pharma Ltd processed 619 shipments to 22 destination countries.
What Syringe Formulations Does Gland Pharma Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PREFILLED SYRINGE | $6.7M | 147 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PRE-FILLED SYRINGE | $1.9M | 42 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0.4ML PRE-FILLED SYRINGE | $1.9M | 43 |
| (LOW MOLECULAR WEIGHT HEPARIN) ENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGES | $1.8M | 40 |
| (LOW MOLECULAR WEIGHT HEPARIN) ENOXAPARIN SODIUM INJECTION USP, 40MG in 0.4ml PRE-FILLED SYRINGES | $1.7M | 43 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0 4ML PREFILLED SYRINGE | $1.6M | 31 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 30MG IN 0.3ML PREFILLED SYRINGE | $1.1M | 25 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PREFILLED SYRINGENOS | $777.4K | 18 |
| (LOW MOLECULAR WEIGHTHEPARIN) ENOXAPARINSODIUM INJECTION USP,40MG IN 0.4ML PRE-FILLEDSYRINGES | $700.0K | 14 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 60MG IN 0.6ML PRE-FILLED SYRINGE | $695.6K | 16 |
Gland Pharma Ltd exports 198 distinct Syringe formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, with 147 shipments worth $6.7M.
Regulatory Requirements: Exporting Syringe to Key Markets
What Gland Pharma Ltd must comply with to export Syringe to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Gland Pharma Ltd Compare to Nearest Syringe Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | GLAND PHARMA LTD ★ | $30.9M | 619 | 22 | $50.0K |
| 2 | GLAND PHARMA LIMITED | $11.7M | 234 | 19 | $50.0K |
| 3 | INDIAN IMMUNOLOGICALS LIMITED | $7.9M | 158 | 20 | $50.0K |
Gland Pharma Ltd ranks #1 among 291 Indian Syringe exporters. Average shipment value of $50.0K compared to the market average of $231.1K. The closest competitors by value are GLAND PHARMA LIMITED and INDIAN IMMUNOLOGICALS LIMITED.
Which Indian Ports Ship Syringe Exports?
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 447 | 12.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 290 | 8.2% |
| SAHAR AIR | 282 | 8.0% |
| AHEMDABAD AIR | 219 | 6.2% |
| AHEMDABAD AIR ACC (INAMD4) | 209 | 5.9% |
| DELHI AIR | 187 | 5.3% |
| NHAVA SHEVA SEA (INNSA1) | 138 | 3.9% |
| HYDERABAD ICD (INSNF6) | 127 | 3.6% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Syringe — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Syringe shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gland Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 853 individual customs records matching Gland Pharma Ltd exporting Syringe, covering 198 formulations to 29 countries via 56 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 154+ countries, 751+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Syringe Export Data from Gland Pharma Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gland Pharma Ltd's Syringe exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gland Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Syringe Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gland Pharma Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Syringe. For current shipment-level data, contact TransData Nexus.